Stifel Reiterates Hold Rating, $70 Price Target on Globus Medical (GMED) Despite "Surprising CEO Resignation"
Tweet Send to a Friend
Stifel analyst Mathew Blackman reiterated a Hold rating and $70.00 price target on Globus Medical (NYSE: GMED), following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
